Escolar Documentos
Profissional Documentos
Cultura Documentos
RESUMO
1 INTRODUÇÃO
2 METODOLOGIA
3 RESULTADOS
62,10%
51,30%
48,70%
37,90%
13,60%
10,80% 10,90%
21,80%
10,80%
Q5 Q6 Q7 Q8
5,50%
SIM NÃO
Q1 Q2 Q3 Q4
MENINOS 87,50%
QUESTIONÁRIO SOBRE HPV
95,80% 70,10%
62,50%
QUESTIONÁRIO SOBRE HPV
88,90% 54,10%
75%
45,90%
54,20% 37,50%
29,90%
45,80%
25% 12,50%
11,10%
4,20%
Q5 Q6 Q7 Q8
Q1 Q2 Q3 Q4 SIM NÃO
4 CONSIDERAÇÕES FINAIS
REFERÊNCIAS
Nakagawa, J. T., Schirmer, J., & Barbieri, M. (2010). Vírus HPV e câncer de
colo de útero. *Revista Brasileira de Enfermagem*, 63, 307-311.
Mariani, L., Vici, P., Suligoi, B., Checcucci-Lisi, G., Drury, R., Chellini, E., ... &
Paba, P. (2018). Early Direct and Indirect Impact of Quadrivalent HPV
(4HPV) Vaccine on Genital Warts: A Systematic Review. *Advances in
Therapy*, 35(12), 2081-2093.
Brisson, M., Van de Velde, N., Franco, E. L., Drolet, M., Boily, M. C., & Group,
H. P. V. V. W. (2011). Incremental impact of adding boys to current human
papillomavirus vaccination programs: role of herd immunity. *The Journal
of infectious diseases*, 204(3), 372-376.
Kavanagh, K., Pollock, K. G., Potts, A., Love, J., & Cuschieri, K. (2017).
Changes in the prevalence of human papillomavirus following a national
bivalent human papillomavirus vaccination programme in Scotland: a 7-
year cross-sectional study. *The Lancet Infectious Diseases*, 17(12), 1293-
1302.
Machalek, D. A., Garland, S. M., Brotherton, J. M., Bateson, D., McNamee, K.,
Stewart, M., ... & Hillman, R. J. (2016). Very low prevalence of vaccine
human papillomavirus types among 18 to 35 year old Australian women 9
years following implementation of vaccination. *The Journal of infectious
diseases*, 214(9), 1316-1323.